Related Experiment Video
Updated: May 29, 2026

Preparation of a Blood Culture Pellet for Rapid Bacterial Identification and Antibiotic Susceptibility Testing
Published on: October 15, 2014
Fatal Panton-Valentine leukocidin-positive MSSA toxic shock syndrome: a call for rapid virulence detection and
Congcong Zhao1,2, Rongrong Ren3, Wei Wu1,4
1Department of Pharmacy, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Background:
Toxic shock syndrome (TSS) is a rare but potentially life-threatening toxin-mediated infection. Cases associated with Panton-Valentine leukocidin (PVL)-producing Staphylococcus aureus are particularly uncommon in clinical settings and remain insufficiently documented in the literature.
Objectives:
This report aims to strengthen clinical understanding of TSS caused by methicillin-sensitive Staphylococcus aureus (MSSA) harboring PVL, assess optimal antimicrobial strategies for treating MSSA infections, minimize the risk of therapeutic failure, and offer insights that may inform timely diagnosis and effective clinical management.
Methods:
We present a case involving a 26-year-old female patient with MSSA isolated from multiple anatomical sites who initially received vancomycin before being diagnosed with PVL-positive MSSA-induced TSS. Therapeutic efficacy was evaluated by integrating her clinical course with contemporary evidence on the management of severe MSSA infections. In addition, treatment considerations for highly virulent MSSA infections with distinct clinical characteristics were examined.
Results:
The patient's clinical course enabled a comparative assessment of β-lactam antibiotics, such as cefazolin, versus glycopeptide agents, such as vancomycin, in the management of MSSA infections. Upon confirmation of MSSA, early transition to targeted therapy with cefazolin or anti-staphylococcal penicillins may be considered. In critically ill patients, early virulence gene testing is important for rapid identification of PVL-positive strains.
Conclusions:
PVL-positive MSSA may be associated with a fulminant, atypical toxic shock syndrome-like phenotype characterized by disseminated pustulosis and pancytopenia, which should raise immediate suspicion of a toxin-driven process. This case suggests that de-escalation from vancomycin to a β-lactam antibiotic upon MSSA confirmation may be a key therapeutic strategy. Increased vigilance, rapid virulence factor testing, and early aggressive management are important to improving outcomes.
Insights
Panton-Valentine leukocidin (PVL)-producing Staphylococcus aureus can cause severe toxic shock syndrome (TSS). Early de-escalation from vancomycin to beta-lactams and rapid virulence testing are crucial for effective management of PVL-positive MSSA infections.
Area of Science:
- Infectious Diseases
- Microbiology
- Clinical Medicine
Background:
- Toxic shock syndrome (TSS) is a rare, life-threatening infection.
- Panton-Valentine leukocidin (PVL)-producing Staphylococcus aureus (MSSA) cases are uncommon and poorly documented.
Purpose of the Study:
- Enhance understanding of PVL-positive MSSA-induced TSS.
- Assess optimal antimicrobial strategies for MSSA infections.
- Minimize therapeutic failure and guide clinical management.
Main Methods:
- Case report of a 26-year-old female with PVL-positive MSSA-induced TSS.
- Evaluation of vancomycin vs. beta-lactam therapy (e.g., cefazolin).
- Integration of clinical course with evidence on severe MSSA infection management.
Main Results:
- PVL-positive MSSA can present with a severe TSS-like phenotype, including pustulosis and pancytopenia.
- Early transition to beta-lactam antibiotics (cefazolin) may be beneficial.
- Virulence gene testing is critical for identifying PVL-positive strains in severe cases.
Conclusions:
- PVL-positive MSSA infections warrant high clinical suspicion for a toxin-driven process.
- De-escalation from vancomycin to beta-lactams upon MSSA confirmation is a key strategy.
- Vigilance, rapid testing, and early management improve outcomes.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Rapid Identification of Pathogens
Automated Microbial Diagnostics
Mechanism of Antibiotic Resistance in MRSA
Acute Pyelonephritis II: Diagnostic Studies and Management
Regulation of Bacterial Virulence
